Frederic Boned's most recent trade in Balchem Corp. was a trade of 5,200 Stock Option done . Disclosure was reported to the exchange on Feb. 12, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Balchem Corp. | Frederic Boned | SVP/GM, Human Nutri. & Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 5,200 | 5,200 | - | - | Stock Option | |
Balchem Corp. | Frederic Boned | SVP/GM, Human Nutri. & Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 1,580 | 6,730 (0%) | 0% | 0 | Common Stock | |
Balchem Corp. | Frederic Boned | SVP/GM, Human Nutri. & Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 4,500 | 4,500 | - | - | Stock Option | |
Balchem Corp. | Boned Frederic | SVP/GM, Human Nutri. & Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 1,380 | 5,322 (0%) | 0% | 0 | Common Stock | |
Balchem Corp. | Frederic Boned | SVP/GM, Human Nutri. & Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 2,600 | 2,600 | - | - | Stock Option | |
Balchem Corp. | Frederic Boned | SVP/GM, Human Nutri. & Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 770 | 3,792 (0%) | 0% | 0 | Common Stock |